RxDoctor Payments Data

Elizabeth Mortazavi, DO

Interventional Pain Medicine · Thibodaux, LANPI 1164956389

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.2%.

$6,654in general payments, 2019–2025

Across 85 payments — averaging $78.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Nevro Corp.$1K
  • Spinal Simplicity, LLC$1K
  • Boston Scientific$1K
  • Abbott$322
  • SPR Therapeutics, Inc$212
  • plus $739 from 13 others

What the payments were for

  • Speaking & faculty fees$1,18618%
  • Travel & lodging$2,34835%
  • Food & beverage$3,12047%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,654 in reported general payments places this provider in the 60th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$103,363
Medicare patients
170
Services billed
2,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen751$21,195
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen380$11,281
Celecoxib458$7,752
Buprenorphine25$7,021
Gabapentin551$6,323
Tizanidine Hcl274$5,220
Tramadol Hcl235$4,390
Pregabalin346$3,823
Duloxetine Hcl183$2,414
Methocarbamol195$2,332
Lidocaine21$1,803
Cyclobenzaprine Hcl78$1,203
Oxycodone Hcl50$863
Diclofenac Sodium56$851
Baclofen33$445

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →